WORLD-FIRST LUNG CANCER VACCINE TRIALS LAUNCHED ACROSS SEVEN COUNTRIES

Summary from the TLDR newsletter

BioNTech has begun trials for BNT116, an mRNA lung cancer vaccine, in 34 research sites across the UK, US, Germany, Hungary, Poland, Spain, and Turkey. The vaccine works by presenting the immune system with tumor markers to prime the body to fight cancer cells expressing those markers. It aims to strengthen a person's immune response to cancer while leaving healthy cells untouched. The treatment is simple to deliver - patients receive a round of shots every week for six consecutive weeks and then every three weeks for 54 weeks.